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Abstract
Introduction: Neurofibromatosis type 1 is an autosomal dominant disorder that occurs across all ethnic groups
and affects approximately one in 4000 individuals. One of the most noticeable characteristics of the disease is the
development of neurofibromas.
Case presentation: A total of 258 patients (131 women, 127 men) with neurofibromatosis type 1 were evaluated
between 1994 and 2004 in our hospital’s dermatology department. Nine patients (3.45%, 95% confidence limits
1.22 to 5.68) had neurofibromas of the breast. One of these nine patients presented with an extensive congenital
plexiform neurofibroma in the outer quadrants of her right breast, extending to the nipple-areolar complex.
Meanwhile, three patients had more than one neurofibroma on the nipple-areolar complexes. Three patients had a
family history of neurofibroma. Over the years 1994 to 2004, the cutaneous lesions were not associated with any
malignancies. Presenting symptoms were related to conditions such as increasing size of the mass, and associated
loss of function and pain.
Conclusions: This study suggests that the changes are limited to particular subgroups. That neurofibromatosis is
more prevalent in women (7 women and 2 men) suggests that being female could be a susceptibility factor for
the development of neurofibromas of the nipple-areolar complexes. There are few reports in the literature
describing breast carcinomas in association with von Recklinghausen disease. It has been speculated that the
presence of multiple neurofibromas of the breast may obscure a breast mass at palpation, leading to a delay in
clinical detection. We suggest that patients with neurofibromas of the breast have more rigorous clinical and
mammographic screening of the breast during adulthood to determine the presence or absence of malignancies.
The finding that both the neurofibromatosis type 1 gene and a breast cancer predisposition gene are located in
close proximity on chromosome 17q makes the association of these two conditions intriguing.
Introduction
Neurofibromatosis type 1 (NF1) is one of the most com-
mon autosomal dominant disorders as it affects approxi-
mately 1 in 4000 individuals [1]. It is associated with
deletions, insertions or mutations in the NF1 gene,
witch is a tumour suppressor gene located in the peri-
centromeric region of chromosome 17. A substantial
body of evidence supports the hypothesis that neurofi-
bromin, the NF1 gene product, has a role in cell growth
and differentiation [1].
NF1 is characterized by a variety of benign and malig-
nant lesions, such as multiple café-au-lait spots, inguinal
and axillary freckling, cutaneous neurofibromas, plexi-
form neurofibromas, optic nerve gliomas, skeletal
abnormalities, phaeochromocytomas, and malignant per-
ipheral nerve sheath tumours. The morbidity and mor-
tality caused by NF1 are dictated by the occurrence of
complications that involve any of the body systems.
Manifestations of NF1 vary at different times in an indi-
vidual’s life. Substantial variability also exists among
affected members of a single family. At least half of the
patients with NF1 will have only cutaneous involvement
that can be a source of psychological burden as a result
of cosmetic disfigurement [2].
One of the most noticeable characteristics of the dis-
ease is the development of neurofibromas, especially on
the trunk and limbs. Four clinically and morphologically
distinct variants of neurofibromas occur in neurofibro-
matosis 1: cutaneous lesions, localized intraneural
tumours, plexiform neurofibromas, and massive soft * Correspondence: istderm@unipa.it
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as sessile and dome-shaped, sometimes pedunculated,
flesh-coloured, and with soft papules or nodules.
Patients with cutaneous neurofibromas are usually
asymptomatic, but they can be pruritic. On the other
hand, subcutaneous neurofibromas are usually larger
than dermal lesions and consist of fusiform swelling that
occurs along the sheaths of peripheral nerves. They do
not infiltrate surrounding tissues but can grow to an
enormous size.
About 95% of patients have discrete benign neurofi-
bromas. These lesions do not usually develop before
adolescence, may be quite variable in size, and may
increase in number, as the patient grows older. The
plexiform variant of neurofibromas involves single or
multiple nerve fascicles that often arise from the
branches of major nerves and form a mass of tangled,
rope-like structures that feel similar to a “bag of worms”
on palpation and can be associated with massive soft-tis-
sue overgrowth, leading thus to functional impairment.
Most plexiform neurofibromas are present at birth or
become apparent during the first years of a life in 30%
of patients diagnosed with neurofibromatosis type 1 [3].
A total of 258 patients (131 women, 127 men) with
neurofibromatosis type 1 were evaluated between 1994
and 2004 in our hospital’s Dermatology Department. All
patients included in this study have NF1 as defined by
the National Institute of Health Consensus Conference
[4,5]. We excluded cases described as segmental NF or
those which were classified as “other type of NF”.
In this report we present 9 patients with neurofibro-
mas of the nipple-areolar complex.
Case presentation
A systematic multidisciplinary clinical investigation and
familial enquiry were performed for each patient (Table 1).
Case report 1
A 44-year-old man presented with multiple café-au-lait
spots and neurofibromas. Upon inspection of his chest
and breasts, a cutaneous neurofibroma was noted on his
left nipple-areolar complex. He had no family history of
neurofibromatosis.
Case report 2
The patient was a 66-year-old man with neurofibroma-
tosis type 1. His mother and all his siblings had neurofi-
bromatosis 1. Clinical examination showed that he had
café-au-lait spots and multiple neurofibromas in a gen-
eralized distribution. Moreover, a large subcutaneous
neurofibroma of approximately 8 cm in diameter was
palpable on his occipital region. A neurofibroma was
also noted on his right nipple.
Case report 3
The patient was a 32-year-old woman with few scattered
neurofibromas and café-au-lait spots. She had no family
history of neurofibromatosis. Examination revealed a
neurofibroma of 10 mm in diameter involving the cuta-
neous and subcutaneous tissues involving her left breast
to the areola. Two small neurofibromas were also noted
in close proximity to her left nipple.
Case report 4
A 50-year-old woman was referred to our hospital for
evaluation of multiple neurofibromas on her trunk, head
and neck. She also had several café-au-lait spots on her
axilla. She had no family history of neurofibromatosis.
Physical examination showed two neurofibromas on the
right nipple-areolar complex of this patient. The lesions
were large and pedunculated, and extended outward 2
cm and 6 cm respectively from the areolar region (Fig-
ure 1). These neurofibromas were seen to increase in
size over a 4-year period. Mammography showed dense
cutaneous well-circumscribed pedunculated nodules
arising from the areolar region.
Case report 5
The patient was a 70-year-old woman who presented
with large neurofibromas, café-au-lait spots and scolio-
sis. She reported that her mother had neurofibromatosis
type 1. Upon examination of her breasts a neurofibroma
on the left nipple-areolar complex was noted.
Table 1 Nine cases of patients with NF1 presenting with neurofibromas of the breast protruding from the nipple-
areolar complexes.
Case
no
Age Sex Family
history
Histopathology of neurofibromas of
the nipple-areolar complexes
Plexiform
neurofibromas
Axillary
freckling
Café au
lait spots
Cutaneous
neurofibromas
Coexisting
disease
1 44 M No Neurofibroma No Yes Yes
2 66 M Yes Neurofibroma Yes Yes Yes
3 32 F No Neurofibroma No Yes Yes
4 50 F No Neurofibroma Yes Yes Yes
5 70 F Yes Neurofibroma No Yes Yes Scoliosis
6 51 F Yes Neurofibroma No Yes Yes
7 74 F No Neurofibroma Yes Yes Yes
8 40 F No Neurofibroma Yes Yes Yes Yes
9 35 F No Plexiform neurofibroma Yes No Yes Yes Vitiligo
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A 51-year-old woman presented with numerous neurofi-
bromas, several café au lait spots and NF1 family ante-
cedents. On examination, multiple cutaneous
neurofibromas were noted on her chest and breasts. In
particular, bilateral large serpiginous, pedunculated neu-
rofibromas were prominent. The lesions were painful
and extended outward at least 7 cm to 8 cm from the
nipple and areola, thus deforming both nipples (Figure
2). Mammography showed bilateral dense breasts, as
well as multiple, cutaneous, well-circumscribed, pedun-
culated nodules arising from both nipple-areolar regions.
Case report 7
The patient was a 74-year-old woman with no family
history of neurofibromatosis. On examination, there was
noted skin involvement with numerous patches of cuta-
neous pigmentation and extensive cutaneous tumours.
The hue abnormalities were light to dark brown and dif-
fuse all over the skin. The neurofibromas were soft, flesh
coloured, and non-painful tumours that ranged in size
from several millimetres to many centimetres in dia-
meter. Moreover, the patient had a neurofibroma pro-
jecting over the left nipple-areolar complex, which
markedly deformed her nipple.
Case report 8
A 40-year-old woman without family history of neurofi-
bromatosis presented to our department with café-au-
lait spots spread all over her body. The café-au-lait
macules were flat, light to dark brown and well-circum-
scribed areas that range from a few millimetres to sev-
eral centimetres in diameter. Intertriginous freckling,
discrete cutaneous neurofibromas, and diffuse subcuta-
neous neurofibromas were also observed. Upon chest
and breast examination, a neurofibroma close to her
right nipple and a nodular plexiform neurofibroma on
the chest’s right anterior region were found. The nodule
was tender and firm along the nerve plexuses.
Case report 9
The patient was a 35-year-old woman with no family
history of neurofibromatosis. An inspection of her skin
revealed extensive congenital plexiform neurofibroma in
the outer quadrants of her right breast that extended to
the nipple-areolar complex and to the homolateral axil-
lary region and arm (Figure 3). The lesion infiltrates the
nerve itself and the surrounding tissues, which was lead-
ing to soft tissue overgrowth and causing dysfunction
and disfigurement. Dermatological exploration also
showed some smooth, margined, light-brown pigmented
macules on her chest that varied in size and configura-
tion. Moreover, a segmental vitiligo characterized by
unilateral macules in dermatomal distribution was pre-
sent on her left lower limb.
Microscopic findings of biopsy specimens of the
lesions on the nipple-areolar complexes were obtained
Figure 1 Case 4. The lesions are large and pedunculated
protruding 2 cm and 6 cm, respectively, from the nipple-areolar
complexes.
Figure 2 Case 6. The lesions deforming both nipples and areolar
regions.
Figure 3 Case 9. The extensive congenital plexiform neurofibroma
involved the outer quadrants of her right breast and extends to the
nipple-areolar complex and to the homolateral axillary region and
arm.
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grounds. Hematoxylin and eosin stained sections from
sections that were fixed with formalin and embedded in
paraffin were prepared. On histology, the nipple lesions
of patients 1 to 8 were identified as neurofibromas. The
neurofibromas contained interlacing bundles of elon-
gated cells with dark staining nuclei. The cells were
associated with strands of collagen, and small to moder-
ate amounts of mucoid material separated the cells from
the collagen. Occasional mast cells and lymphocytes
were also present in the stroma. In particular, the 4
th
and 6
th patients had neurofibromas that were composed
of widely spaced cells devoid with elongated nuclei and
scant cytoplasm and embedded in matrices that were
rich in mucopolysaccharide and variably collagenous
(Figures 4a and 4b). The collagen fibres were typically
delicate and lay within a matrix that was variable, abun-
dant and rich in mucopolysaccharide.
Histological finding showed plexiform neurofibroma in
the 9
th patient. The neurofibroma is located in both the
dermal and subcutaneous tissues. The neurofibroma
cells surround the adipose tissue. Tactile differentiation
was apparent, and the pseudomeissnerian corpuscles
were found to be spherical and aggregated (Figure 5).
In all the patients we describe, clinical and histopatho-
logical examination at the time of their first presenta-
t i o n ,a sw e l la st h e i rs u b s e q uent examinations, did not
show an association with breast carcinoma.
Discussion
Nine out of 258 patients, or 3.45% of the total number
(95% confidence limits: 1.22 to 5.68), of the patients
evaluated with a diagnosis of NF1 in our dermatology
department harboured neurofibromas of the breast. Of
this number, one patient presented with an extensive
congenital plexiform neurofibroma in the outer quad-
rants of the right breast that extended to the nipple-
Figure 4 Case 4. The neurofibroma is composed of widely spaced cells with elongated nuclei and scant cytoplasm and embedded in
mucopolysaccaride-rich, variably collagenous matrix (hematoxylin and eosin staining, original magnification (A) ×125, and (B) ×250).
Figure 5 Case 9. The cell formations resemble Wagner-Meissner
corpuscles. These are spherical and aggregated (haematoxylin and
eosin staining; original magnification ×640).
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one neurofibroma on the nipple-areolar complexes.
With 127 male patients and 131 female patients studied,
the gender distribution of the cohort was comparable.
The most striking and singular observation of this study
was the gender difference. We found a significant num-
ber of women (7 patients) with neurofibromas of the
nipple-areolar complexes. A family history was reported
in 3 patients. Over the years, the cutaneous lesions were
not associated with malignancies.
NF1, known also as Von Recklinghausen disease, is an
autosomal dominant hamartomatous disease primarily
involving the neuroectodermal and mesodermal tissues.
Although the clinical manifestations of NF1 are well
known [6], the course of the condition in individual
patients is largely unpredictable. This unpredictability
and the general progression of the disease is a major
concern for most patients with NF1 and their families
[7].
NF1 primarily affects the peripheral nervous system
and is often characterized by large numbers of
neurofibromas.
Neurofibromas of the breast are quite rare manifesta-
tions of patients with NF1. In such cases, they occur on
the nipple-areolar complexes [8,9], and their frequency
increases with age. Reviewing the literature, several
clinic-based series of patients with NF1 have been
reported, but only a few reports have specifically exam-
ined neurofibromas of the nipple-areolar complexes
[10,11]. In this study, we present information about the
clinical features of neurofibromas in patients with NF1,
with specific regard to the location of tumours and pre-
senting symptoms. To the best of our knowledge, this
series is the largest investigation of patients with neuro-
fibromas of the nipple-areolar complexes and NF1 to
date. Previous studies do not provide information on
gender, or include fewer patients [8-11].
In our patients, neurofibromas of the nipple-areolar
complexes were generally soft, flattened, or peduncu-
lated skin lesions that protrude from the nipple-areolar
regions and eventually deformed the nipples. The pre-
senting symptoms were related to increasing size of the
mass, associated loss of function and the feeling of pain.
On mammography, the typical appearance was of a sin-
gle or multiple skin lesions projecting over the mam-
mary parenchyma. Portions of the lesions were outlined
by air, demonstrating well-defined smooth margins [10].
T h eo b s e r v a t i o no faf e m a l ep r e d o m i n a n c ei no u r
group suggests that female gender could be a suscept-
ibility factor for the development of neurofibromas of
the nipple-areolar complexes. To estimate the real fre-
quency of the neurofibromas of the nipple-areolar com-
plexes and to determine whether there is a familial
tendency, a detailed family history and complete
physical examination of affected patients and family
members are warranted.
This study suggests that such changes are limited to
particular subgroups. The mechanisms by which muta-
tions of the NF1 gene produce these phenotypic effects
are unknown, but understanding how they do so may
provide an important clue to the pathogenesis of the
more serious manifestations of NF1.
The phenotype of NF1 is highly variable, and some
affected individuals are more likely than others to
develop certain features of the disease. Although various
abnormalities, including chromosome rearrangements,
deletions, insertions, duplications, and base substitutions
have been reported, the wide diversity of mutation types
and wide range of variable expression of neurofibroma-
tosis 1 have made it difficult to establish genotype to
phenotype correlations. The one exception to the lack
of genotype to phenotype correlation is the case of
entire gene deletions that appears to be associated with
the early onset of a large number of cutaneous neurofi-
bromas, minor facial anomalies, and developmental
delay [12].
Certain clinical features of NF1 share a common
pathogenesis, while other features develop through dif-
ferent pathogenic mechanisms. Further clinical, epide-
miological, pathological, and molecular studies are
necessary to elucidate the basis for these associations in
patients with NF1.
NF1 also represents a major risk factor in the develop-
ment of several malignancies, particularly malignant per-
ipheral nerve sheath tumours (MPNST) [13], optic
gliomas, other gliomas, rhabdomyosarcoma, astrocytoma
and neurofibrosarcoma and leukemias. The average life
expectancy of patients with NF1 is probably reduced by
10 to 15 years, and malignancy is the most common
cause of death [11]. In addition, there are few cases in
the literature describing invasive ductal carcinomas in
association with von Recklinghausen disease [10]. Breast
cancer has a lifetime incidence of up to one in eight
women. Owing to the paucity of reports of NF1 and
breast cancer, Riccardi commented that an association
between these two types of diseases cannot be firmly
established, but recommended molecular analysis of
breast cancers in NF1 patients [14]. The finding that
both the NF1 gene and a breast cancer predisposition
gene (BRCA1) are located in close proximity on chro-
mosome 17q makes the association of these two condi-
tions intriguing.
It has been speculated that the presence of multiple
neurofibromas of the breast, which can develop both on
the surface of the skin and subcutaneously, may obscure
a breast mass at palpation, leading thus to a delay in
clinical detection [10]. Patients usually do not seek med-
ical assistance because they suppose that it is simply a
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If a suspected breast lesion is demonstrated in a patient
with NF1, radiological imaging of the mass is recom-
mended in order to obtain further diagnostic informa-
tion. Careful mammographic interpretation in these
patients is also important [10].
Conclusions
This report aims to stimulate interest in the unusual
presentation of neurofibromas on the nipple-areolar
complexes. It is hoped that clinicians will become aware
that breast cancer can be difficult to detect in these
patients, leading thus to a delay in clinical detection.
We suggest that patients with neurofibromas of the
breast have more rigorous clinic and mammographic
screening of the breast during adulthood to determine
t h ep r e s e n c eo ra b s e n c eo fm a l i g n a n c i e s .T h ef i n d i n g
that both the NF1 gene and a breast cancer predisposi-
tion gene (BRCA1) are located in close proximity on
chromosome 17q makes the association of these two
conditions intriguing [15], even if the risk of developing
malignant transformation in neurofibromas of the nip-
ple-areolar complexes is rare.
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